COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark

Author(s):: Shen, Q.; Joyce, E.E.; Ebrahimi, O.V.; Didriksen, M.; Lovik, A. (0000-0002-6397-5011); Sævarsdóttir, K.S.; Magnúsdóttir, I.; Mikkelsen, D.H.; Unnarsdóttir, A.B.; Hauksdóttir, A.; Hoffart, A.; Kähler, A.K.; Thórdardóttir, E.B.; Eythórsson, E.; Frans, E.M.; Tómasson, G.; Ask, H.; Hardardóttir, H.; Jakobsdóttir, J.; Lehto, K.; Lu, L.; Andreassen, O.A.; Sullivan, P.F.; Pálsson, R.; Erikstrup, C.; Ostrowski, S.R.; Werge, T.; Aspelund, T.; Pedersen, O.B.V.; Johnson, S.U.; Fang, F.; Valdimarsdóttir, U.A.

Physical symptomLong covidCohortCOVID-19

Date issued: 2023-12-01
Language: English
Is part of: The Lancet Regional Health Europe (2023), Vol. 35, p. 1-12, e100756
hdl: 1887/3713912
doi: 10.1016/j.lanepe.2023.100756
URL: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00175-8/fulltext